Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials

J Geldof, N Iqbal, JF LeBlanc… - The Lancet …, 2022 - thelancet.com
Perianal fistulising Crohn's disease is an aggressive disease phenotype that can have a
substantial detrimental impact on patients' quality of life. Current biological understanding of …

Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature

M Attauabi, J Burisch, JB Seidelin - Scandinavian Journal of …, 2021 - Taylor & Francis
Background Although the number of biological therapies for the treatment of Crohn's
disease (CD) is rapidly increasing, their efficacy in inducing healing of fistulas in perianal …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

J Torres, S Bonovas, G Doherty… - Journal of Crohn's …, 2020 - academic.oup.com
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians …

ECCO guidelines on therapeutics in Crohn's disease: surgical treatment

M Adamina, S Minozzi, J Warusavitarne… - Journal of Crohn's …, 2024 - academic.oup.com
This article is the second in a series of two publications on the European Crohn's and Colitis
Organisation [ECCO] evidence-based consensus on the management of Crohn's disease …

Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial

C Zhou, M Li, Y Zhang, M Ni, Y Wang, D Xu… - Stem cell research & …, 2020 - Springer
Background Crohn's fistula-in-ano is a refractory disease in colorectal and anal surgery.
Although autologous adipose-derived stem cell (ADSC) has been used in the treatment of …

ECCO Topical review optimising reporting in surgery, endoscopy, and histopathology: collaboration between S-ECCO, EduCom, H-ECCO

M Adamina, R Feakins, M Iacucci… - Journal of Crohn's …, 2021 - academic.oup.com
Abstract Background and Aims Diagnosis and management of inflammatory bowel diseases
[IBD] requires a lifelong multidisciplinary approach. The quality of medical reporting is …

Клинические рекомендации по диагностике и лечению болезни Крона у взрослых (проект)

ВТ Ивашкин, ЮА Шелыгин, ДИ Абдулганиева… - …, 2020 - elibrary.ru
Этиология воспалительных заболеваний кишечника (ВЗК), в том числе БК, не
установлена: заболевание развивается в результате сочетания нескольких факторов …

Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021

H Nakase, M Esaki, F Hirai, T Kobayashi… - Journal of …, 2023 - Springer
Background We aimed to develop criteria for treatment intensification in patients with (1)
luminal Crohn's disease (CD),(2) CD with perianal disease and/or fistula,(3) CD with small …

Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn's disease: systematic review and network meta-analysis of …

M Shehab, F Alrashed, V Heron… - Inflammatory Bowel …, 2023 - academic.oup.com
Background The medical treatment of fistulizing Crohn's disease (CD) remains a challenge
to clinicians. Over the last 20 years, biologic therapies have been the mainstay of medical …

Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis

GMG Brewer, G Salem, MA Afzal… - BMJ Open …, 2021 - bmjopengastro.bmj.com
Background Perianal Crohn's disease (pCD) is a debilitating complication affecting up to
30% of Crohn's disease (CD) population, leading to increased morbidity, mortality and …